Log In
Print this Print this

cethromycin (IV Restanza)

  Manage Alerts
Collapse Summary General Information
Company Advanced Life Sciences Holdings Inc.
DescriptionIV ketolide antibiotic
Molecular Target Ribosomal 50S subunit
Mechanism of ActionRibosomal 50S subunit inhibitor
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPreclinical
Standard IndicationPneumonia
Indication DetailsTreat community acquired pneumonia in adults
Regulatory Designation
PartnerAbbott Laboratories;
Pfizer Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today